Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1628 1629
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18362034 | PIPERIDINYLPYRIDINYLCARBONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN | Non-Final OA | Boehringer Ingelheim International GmbH |
| 18285521 | ANTI-ANXIETY COMPOSITION | Non-Final OA | SUNTORY HOLDINGS LIMITED |
| 18646917 | FORMULATIONS FOR TREATMENT OF POST-TRAUMATIC STRESS DISORDER | Non-Final OA | Glytech LLC |
| 18347811 | Compositions And Methods For Treating Gulf War Illness | Non-Final OA | The United States Government As Represented By The Department of Veterans Affairs |
| 18347732 | USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID IN THE TREATMENT OF CANCER | Non-Final OA | Ovid Therapeutics Inc. |
| 18549366 | BICYCLIC PHENOL COMPOUNDS AND USE THEREOF | Non-Final OA | MEDSHINE DISCOVERY INC. |
| 18558756 | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MPNST | Non-Final OA | The John Hopkins University |
| 18558763 | Diazepane Derivatives, Processes for their Preparation, and Uses thereof for the Amelioration, Prevention and/or Treatment of Mental and Neurological Diseases | Non-Final OA | 2N Pharma ApS |
| 18280611 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE OR DEMENTIA | Non-Final OA | Nxera Pharma UK Limited |
| 18554951 | WEE1 COMPOUND FOR TREATING UTERINE SEROUS CARCINOMA | Non-Final OA | Recurium IP Holdings, LLC |
| 18348332 | APPLICATION METHOD OF POTASSIUM ION CHANNEL BLOCKER IN PREPARATION OF DRUGS FOR TREATING LIVER FIBROSIS | Final Rejection | Affiliated Hospital of Zunyi Medical University |
| 18546913 | METHODS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS WITH A SCD-1 INHIBITOR | Non-Final OA | Lipidio Pharmaceuticals, Inc. |
| 18346851 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF LUNG CANCER COMPRISING CANNABIDIOL AND ANTICANCER AGENT AS ACTIVE INGREDIENTS, AND USE THEREOF | Final Rejection | NEOCANNBIO CO., LTD. |
| 17755556 | ANTI-INFLAMMATORY COMPOUNDS FOR USE IN THE TREATMENT OF DERMAL DISORDERS | Non-Final OA | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH |
| 17726096 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION | Final Rejection | Arisan Therapeutics Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy